Rockwell Medical, Inc. (NASDAQ:RMTI - Get Free Report) major shareholder Larson Family Inve Irrevocable bought 57,000 shares of the stock in a transaction that occurred on Thursday, April 10th. The shares were bought at an average cost of $1.07 per share, with a total value of $60,990.00. Following the completion of the purchase, the insider now directly owns 3,527,000 shares in the company, valued at $3,773,890. This represents a 1.64 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
Rockwell Medical Trading Down 0.5 %
NASDAQ:RMTI opened at $1.04 on Wednesday. Rockwell Medical, Inc. has a 1 year low of $0.86 and a 1 year high of $5.15. The stock has a market cap of $35.42 million, a P/E ratio of -20.80 and a beta of 1.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The stock has a 50-day simple moving average of $1.47 and a 200-day simple moving average of $2.26.
Rockwell Medical (NASDAQ:RMTI - Get Free Report) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). Rockwell Medical had a positive return on equity of 8.55% and a negative net margin of 1.25%. The firm had revenue of $24.67 million for the quarter, compared to analysts' expectations of $23.65 million. As a group, analysts anticipate that Rockwell Medical, Inc. will post 0.03 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Marshall Wace LLP boosted its holdings in shares of Rockwell Medical by 17.2% in the fourth quarter. Marshall Wace LLP now owns 596,359 shares of the company's stock valued at $1,217,000 after acquiring an additional 87,685 shares during the period. Renaissance Technologies LLC boosted its stake in Rockwell Medical by 285.8% during the 4th quarter. Renaissance Technologies LLC now owns 442,350 shares of the company's stock worth $902,000 after purchasing an additional 327,678 shares during the period. Geode Capital Management LLC grew its position in Rockwell Medical by 4.3% during the 4th quarter. Geode Capital Management LLC now owns 320,416 shares of the company's stock worth $654,000 after purchasing an additional 13,122 shares during the last quarter. Jane Street Group LLC acquired a new position in Rockwell Medical in the third quarter valued at $534,000. Finally, State Street Corp raised its holdings in shares of Rockwell Medical by 21.5% in the third quarter. State Street Corp now owns 95,004 shares of the company's stock valued at $377,000 after buying an additional 16,800 shares during the last quarter. Institutional investors and hedge funds own 23.31% of the company's stock.
Wall Street Analyst Weigh In
RMTI has been the subject of a number of analyst reports. StockNews.com downgraded Rockwell Medical from a "buy" rating to a "hold" rating in a research report on Friday, December 20th. HC Wainwright lowered their price target on shares of Rockwell Medical from $7.00 to $3.00 and set a "buy" rating for the company in a report on Monday, March 24th.
Get Our Latest Report on RMTI
About Rockwell Medical
(
Get Free Report)
Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
